您的当前位置:首页 > 行业数据 > Q1 2026 start-up financing for gene, cell, and RNA therapy companies
图片属性
图片格式:PNG 图片大小:447KB 图片尺寸:3868*1399
同报告图片
 / 4
Q1 2026 start-up financing for gene, cell, and RNA therapy companies_第1页
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
Q1 2026 start-up financing for gene, cell, and RNA therapy companies_第2页
Q1 2026 start-up financing for gene, cell, and RNA therapy companies_第3页
Q1 2026 start-up financing for gene, cell, and RNA therapy companies_第4页
Q1 2026 start-up financing for gene, cell, and RNA therapy companies_第5页
所属报告: Citeline & ASGCT:2026年第一季度基因、细胞和 RNA 疗法概况报告(英文版)(46页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠